Q3 FY2026 · ended Sep 30, 2026 · Revenue $108.40B, +5.4% YoY · Filed Nov 4, 2026
CVS HEALTH Corp (CVS) files with the SEC under industry code 5912, Retail-Drug Stores and Proprietary Stores. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $108.4 billion and net income of $2.2 billion. Free cash flow was $3.9 billion. As of Sep 30, 2026 it held $49.0 billion in cash and investments and $71.8 billion in total debt.
Revenue
$108.40B
+5.4% vs year-ago quarter
Net income
$2.17B
+154.6% vs year-ago quarter
Operating cash flow
$4.72B
+493.5% vs year-ago quarter
Free cash flow
$3.91B
+3886.7% vs year-ago quarter
EPS
$1.68
+153.7% vs year-ago quarter
Dividend per share
$0.67
+0.0% vs year-ago quarter
Shares outstanding
1.28B
+0.8% vs year-ago quarter
Net cash
$-22.89B
Q3 FY2026
Operating margin
3.6%
TTM
Company profile
- Industry
- Retail-Drug Stores and Proprietary Stores (SIC 5912)
- Listed as
- CVS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Woonsocket, RI
- SEC filer status
- Large accelerated filer
- SEC CIK
- 64803
- Former names
- CVS CAREMARK CORP (until Sep 3, 2014); CVS/CAREMARK CORP (until May 8, 2007); CVS CORP (until Mar 22, 2007); MELVILLE CORP (until Jan 10, 1997)
Other Retail-Drug Stores and Proprietary Stores companies
- Guardian Pharmacy Services, Inc. GRDN
- 111, Inc. YI
- Petmed Express Inc PETS
- Ridgetech Inc. RDGT
- TREES Corp (Colorado) CANN
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $108.4B | $106.1B | $100.4B | $105.7B | $102.9B |
| Operating income | $3.6B | $4.7B | $4.7B | $2.1B | -$3.2B |
| Net income | $2.2B | $3.0B | $2.9B | $2.9B | -$4.0B |
| Diluted EPS | $1.68 | $2.31 | $2.30 | $2.29 | -$3.13 |
| Operating cash flow | $4.7B | $6.3B | $4.2B | $3.4B | $796.0M |
| Free cash flow | $3.9B | $5.7B | $3.4B | $2.6B | $98.0M |
| Total assets | $258.1B | $253.8B | $253.0B | $253.5B | $255.3B |
| Total liabilities | $177.4B | $173.9B | $175.3B | $178.2B | $182.2B |
| Stockholders' equity | $80.5B | $79.7B | $77.5B | $75.2B | $72.9B |
| Cash and investments | $49.0B | $47.2B | $44.2B | $43.3B | $42.8B |
| Total debt | $71.8B | $74.3B | $75.8B | $16.7B | $18.5B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 17, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
All 1003 CVS HEALTH Corp SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.